Filter results
You can narrow down the results using the filters
Publication type
Health topics
Conditions and diseases
Year
8006 results
-
Correct claiming of regional and field nerve block items (18222 and 18225)
This fact sheet provides information to help support the correct billing of Medicare Benefits Schedule Items (MBS) 18222 and 18225 for regional or field nerve blocks. -
Life Saving Drugs Program – Fact sheet for patients
Health professionals can print this fact sheet and give it to patients who are starting treatment under the Life Saving Drugs Program. -
Life Saving Drugs Program – Fact sheet for pharmacists
This fact sheet gives answers to common questions about the role of pharmacies and authorised persons in managing Life Saving Drugs Program (LSDP) medicines. -
Life Saving Drugs Program – Fact sheet for treating physicians
This fact sheet gives answers to common questions about the role of treating physicians in prescribing Life Saving Drugs Program (LSDP) medicines. -
Life Saving Drugs Program – Change of treating physician form
Use this form to help transition a patient’s care to a new physician, where there are no other changes to their treatment or eligibility for the Life Saving Drugs Program (LDSP). -
COVID-19 outbreaks in Australian residential aged care facilities – 27 January 2023
This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services. -
Outcomes of the hospital treatment certification and dual listed MBS items meeting – September 2022
This fact sheet provides our position on the hospital treatment certification. -
Improving communication, coordination and collaboration amongst alcohol and other drug treatment funders
This document looks at the improvements to the National Framework for Alcohol, Tobacco and other Drug Treatment. It looks at improving processes for communication, coordination, and collaboration (CCC) between and amongst alcohol and other drug (AOD) treatment funders. -
COVID-19 vaccination – Geographic vaccination rates – SA4 Indigenous population – 25 January 2023
This report lists the percentage of people who have self identified as Indigenous who have been vaccinated against COVID-19, by SA4. The percentages are further broken down by geographic regions and whether they've had one dose or are fully vaccinated. -
COVID-19 vaccination – Geographic vaccination rates (LGA) – 25 January 2023
These reports list the percentage of people who have been vaccinated against COVID-19 by local government area (LGA). -
COVID-19 vaccine rollout update – 25 January 2023
This presentation, delivered on 25 January 2023, contains an update to Australia's COVID-19 vaccine rollout. -
COVID-19 vaccination – vaccination data – 25 January 2023
This data file contains statistical data about Australia's COVID-19 vaccinations. -
Japanese encephalitis virus – Public relations material
This suite of materials for the 'Japanese encephalitis virus' campaign encourages Australians to cover up, use insect repellent and use a screen or net. -
COVID-19 Vaccines in Australia – A3 poster
This poster provides key differences between each COVID-19 vaccine approved for use in Australia as per the Australian Technical Advisory Group on Immunisation (ATAGI) guidelines. -
What is AN-ACC Class 1 (Admit for Palliative Care)?
This fact sheet explains the separate funding class for individuals who enter residential care for the purpose of receiving palliative care. -
Coronavirus (COVID-19) common operating picture – 27 January 2023
This infographic issued on 27 January 2023 provides a weekly traffic light report of the coronavirus (COVID-19) situation across Australia. -
Life Saving Drugs Program – Pompe disease – Review summary and expert panel recommendations for consumers
This Pompe disease review considered alglucosidase alfa. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers. -
Life Saving Drugs Program – Pompe disease – Review summary and expert panel recommendations
This Pompe disease review considered alglucosidase alfa. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations. -
Life Saving Drugs Program – MPS II – Review summary and expert panel recommendations for consumers
This MPS II review considered idursulfase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers. -
Life Saving Drugs Program – MPS II – Review summary and expert panel recommendations
This MPS II review considered idursulfase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations. -
Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations for consumers
This Gaucher disease review considered 3 enzyme replacement therapies (ERTs), imiglucerase, velaglucerase and taliglucerase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health. -
Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations
This Gaucher disease review considered three enzyme replacement therapies (ERTs), imiglucerase, velaglucerase and taliglucerase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations. -
My Aged Care – Service and Support Portal User Guide Part 1 – Administrator Functions
This user guide explains to administrators how to use the My Aged Care service and support portal. -
Government Provider Management System – Terms of use
This document outlines the terms of use for the Government Provider Management System (GPMS). The GPMS allows aged care service providers to see their Star Ratings. -
National Health and Medical Research Council – Projects funded
A list of National Health and Medical Research Council (NHMRC) projects and the committed funding.